Picture Berlin Partner Top News EIC Accelerator Noah Labs MyoPax 650x100px

Person › Details

Paolo Paoletti (GammaDelta Therapeutics Ltd.)

Paoletti, Paolo (GammaDelta Therapeutics 201705– CEO before Kesios Therapeutics CEO + GSK)

	Organisation	GammaDelta Therapeutics Ltd.
	Group	Takeda (Group)
	Former/major organisation	Kesios Therapeutics Ltd.
	Product	immunotherapy
	Product 2	KES-0001 (Kesios Therapeutics)

Record changed: 2021-10-29

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for Paolo Paoletti

[1] GammaDelta Therapeutics Ltd.. (10/27/21). "Press Release: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic gdT Cell Therapies Addressing Solid Tumors". Osaka & London....
[2] GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]